共 50 条
- [21] Performance characteristics of a tumor-informed circulating tumor DNA (ctDNA) minimal residual disease (MRD) assay in stage 1-3 colorectal cancer (CRC) in clinical practiceANNALS OF ONCOLOGY, 2022, 33 : S347 - S347Somer, B.Mehler, S.Hasenburg, A.Greene, H.Tauer, K.Grothey, A.
- [22] Association of tumor-informed minimal residual disease (MRD) with clinical outcomes for muscle invasive bladder cancer (MIBC): A multicenter retrospective real-world analysisJOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Kommalapati, AjithaLaliotis, GeorgeGlover, MichaelSelig, GrayceKollipara, RevathiMahmood, TamaraShah, SumitHoimes, Christopher J.Stewart, Tyler F.Sharma, ShrutiMalhotra, MeenakshiPajak, NataliaCalhoun, MarkElNaggar, AdamLiu, Minetta C.Basu, ArnabGalsky, Matt D.Tan, Alan
- [23] A tumor-informed, hybrid-capture based ctDNA assay for minimal residual disease (MRD) detection in colorectal cancer (CRC) patients after curative surgeryANNALS OF ONCOLOGY, 2022, 33 (07) : S710 - S711Han, S-W.Heo, S.Lim, Y.Lee, W.Kim, H-P.Kim, S. Y.Bang, D.Park, K. J.Oh, S. T.Yoo, C. S.Kang, S-B.Kim, Y-J.Kim, T-Y.
- [24] Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell cancerCANCER CELL, 2023, 41 (10) : 1749 - +Chen, KezhongYang, FanShen, HaifengWang, ChenyangLi, XiChervova, OlgaWu, ShuailaiQiu, FujunPeng, DiZhu, XinChuai, ShannonBeck, StephanKanu, NnennayaCarbone, DavidZhang, ZhihongWang, Jun
- [25] Monitoring ctDNA dynamics in early breast cancer using a novel ultra-sensitive tumor-informed structural variant approach combining whole-genome sequencing and multiplex dPCRJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Saal, Lao H.Loman, NiklasChen, YilunAlcaide, MiguelBrueffer, ChristianGladchuk, SergiiDalal, HinaMeng, PeiGeorge, Anthony M.Alv, Sofia Birke Spacing DiaeresisSaghir, HaniKimbung, SikerOrnvik, Daniel F. Spacing DiaeresisZander, LinaHoneth, GabriellaHowarth, KarenBorg, AkeEhinger, AnnaMalmberg, MartinRyden, Lisa
- [26] Performance of a tumor-informed molecular residual disease (MRD) assay in resected bladder cancer with mixed or pure variant histology: Analysis of a real-world multicenter cohort.JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 649 - 649Kommalapati, AjithaLaliotis, GeorgeRich, JordanCumarasamy, ShivaramRivero, SamuelSharma, ShrutiPalsuledesai, Charuta C.Malhotra, MeenakshiGalsky, Matt D.Elnaggar, AdamLiu, Minetta C.Sfakianos, John P.Peyton, CharlesFerguson, JamesBasu, Arnab
- [27] Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneityScientific Reports, 5Hua TanJiguang BaoXiaobo Zhou
- [28] Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneitySCIENTIFIC REPORTS, 2015, 5Tan, HuaBao, JiguangZhou, Xiaobo
- [29] Tumor-informed whole genome sequencing of ctDNA from lymph and plasma detects molecular residual disease in HPV-negative head and neck cancer patientsCLINICAL CANCER RESEARCH, 2024, 30 (21)Gu, ZhuoshengLazare, SekaEarland, NoahFrancis, Marra S.Harmon, AdamLong, MeganGreer, AmyVerner, EllenGeorgiadis, AndrewSausen, MarkRamkissoon, ShaktiZevallos, Jose P.Chaudhuri, Aadel A.Jensen, Taylor J.Winckler, Wendy
- [30] Genome-wide map of putative tumor suppressor gene loci involved in bladder cancer progressionMODERN PATHOLOGY, 2001, 14 (01) : 106A - 106ACzerniak, BLi, LZhang, RDYoon, DSKram, ALi, JZRo, JYChaturvedi, VJohnston, DA